MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Exploring the Therapeutic Potential of Microglial Modulation in Parkinson’s Disease: A Study on Structural Synaptic Plasticity

    F. Fares Taie, I. Taravini, L. Rela (Buenos Aires, Argentina)

    Objective: We aim to explore the role of glial cells in Parkinson's disease and assess whether modulating microgliafunction could offer therapeutic benefits. Specifically, we investigate…
  • 2024 International Congress

    A pathology-validated study to investigate the role of Uric Acid in Parkinson’s Disease

    P. Pecoraro, S. Carbone, V. Di Lazzaro, L. Di Biase (Rome, Italy)

    Objective: The aim of this study is to compare plasma uric acid levels between pathology-confirmed and clinically misdiagnosed Parkinson’s disease patients at a single-patient level.…
  • 2024 International Congress

    Burden of Movements Disorders at Initiative Plus Center Hospital

    P. Kiatoko, K. Luse (KINSHASA, The Democratic Republic of the Congo)

    Objective: describe the socio-demographic, clinical characteristics and evolutionary profiles of patients followed for movement disorders Background: The DR Congo specialists in abnormal movements are rare,…
  • 2024 International Congress

    Improving awareness of motor fluctuations in Parkinson’s Disease: an educational patient support program using a waist-worn device.

    N. Caballol, A. ávila, A. Planas-Ballvé, A. Peral, J. Hernández-Vara, S. Belmonte, S. Enríquez, S. Sánchez, D. Cerdán, I. Cabo, N. López-Ariztegui, G. Carvalho, JM. Velázquez, T. Delgado, J. Bocos, B. Ruiz, B. Claramonte, J. Herreros-Rodríguez, D. Santos-García, C. Cores-Bartolomé, J. González-Ardura, D. Ceberino, JM. Salom, R. Rashid, A. Méndez, C. Madrid-Navarro, A. Mulet, D. Rodríguez-Martín, I. Pijuan, I. Tegel (Sant Joan Despí, Spain)

    Objective: To describe the utility of an educational patient support program designed to improve awareness of motor fluctuations (MF) and provide education on motor and…
  • 2024 International Congress

    Utility of Serum α-synuclein Seed Amplification Assay as a Parkinson’s Disease Biomarker

    S. Mosovsky, A. Okuzumi, C. Adler, T. Beach, T. Foroud, G. Serrano, J. Eberling, L. Oliveira, T. Hatano, N. Hattori, B. Mollenhauer, L. Chahine (Pittsburgh, USA)

    Objective: To determine the sensitivity and specificity of serum α-synuclein seed amplification assay (SAA) for Parkinson’s disease (PD) diagnosis in the Systemic Synuclein Sampling Study…
  • 2024 International Congress

    Bedside Assessment of Downgaze Palsy by Amplitude in Patients with Progressive Supranuclear Palsy

    T. Xie, M. Padmanaban, W. Abou Chaar, J. Nichols (Chicago, USA)

    Objective: To assess the specificity and reliability of the bedside assessment of downgaze palsy by amplitude based on the upper edge of the iris relative to…
  • 2024 International Congress

    Impact of Temperature Variation on Emergency Department Visits for Parkinson’s Disease Patients Amongst Two Sites

    S. Vallamkonda, D. Petrosyan, B. Westbrook, N. Kakos, C. Hinds, R. Adlis, A. Menta, J. Lowry, D. Brooks, O. Hofheinz, P. Bhaya, J. Kong, M. Muppirala, A. Benchouia, A. Fajayan, A. Hohler, E. Vaou (Boston, USA)

    Objective: We aim to examine the impact of ambient temperature fluctuations on Parkinson’s disease (PD) patients across two distinct climates. Background: PD is a neurodegenerative…
  • 2024 International Congress

    Vestibular impairment, turning direction and turn progression in Parkinson’s disease

    C. Pongmala, M. van Emde-Boas, P. Kanel, N. Bohnen (Ann Arbor, USA)

    Objective: To explore the correlation between the Romberg test condition 4 and turn progression in most affected and least affected body side directions in people…
  • 2024 International Congress

    Initial Results After Launch of Best Practice Advisory for Contraindicated Agents in Parkinson’s Disease and Related disorders

    N. Shah, N. Chunga, K. Amodeo, I. Richard (Rochester, USA)

    Objective: To describe factors associated with triggering a best practice advisory (BPA) for dopamine-blocking agents (DBA) and report preliminary outcomes in hospitalized persons with Parkinson’s…
  • 2024 International Congress

    Walking reduced the risk of Parkinson’s disease dementia: a retrospective longitudinal follow-up study

    CY. Wei, PY. Chiu (Changhua County, Taiwan)

    Objective: We aimed to test whether the minimal amount of exercise (MAE) of walking, which is practical for people with motor dysfunction, could help prevent…
  • « Previous Page
  • 1
  • …
  • 185
  • 186
  • 187
  • 188
  • 189
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Comorbid Normal Pressure Hydrocephalus with Parkinson’s disease: a call for clinical awareness
  • Clonazepam as a cure or a cause? : Withdrawal Emergent Syndrome
  • Common mistakes in the MoCA test in patients with Parkinson’s Disease in Kyrgyzstan
  • Welcome to the MDS Abstracts Site
  • Effect of marijuana on Essential Tremor: A case report
  • Advanced Search
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley